transplantation

(redirected from Autologous transplantation)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to Autologous transplantation: allogeneic transplantation, Stem cell transplant
References in periodicals archive ?
Experience with autologous transplantation in acute lymphoblastic leukemia is very limited and it can be considered in children with late bone marrow relapse or extramedullar relapse (Table 1) (24, 31).
Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma.
This report suggests that autologous transplantation using a HITH care delivery model is feasible and is safe for appropriately selected patients (40% of our patients) with lymphoma and multiple myeloma.
In the EU, Mozobil would be indicated in combination with granulocyte-colony stimulating factor to enhance mobilization of hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma whose cells mobilze poorly.
Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation.
This is an important development for the company, as it confirms that autologous transplantation may be beneficial for such additional therapeutic indications," said CEO Adrian Harel.
Double autologous transplantation regimens have been used to treat myeloma for the past decade, but their advantage over single transplantation has been unclear until now, Stadtmauer said.
In Europe, Mozobil is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to enhance mobilization of stem cells to the bloodstream for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma whose cells mobilize poorly.
The technique has been shown in Phase I/II clinical trials to reduce the number of cancer cells to below detectable levels, and thus may eliminate the risk of reintroducing cancer to the patient during autologous transplantation.
Mozobil is indicated in the United States for use in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkin's lymphoma and multiple myeloma.

Full browser ?